CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
探析他汀类联合心血管药物治疗冠心病的疗效
Authors
吴艺燕
林燕琼
Publication date
15 January 2019
Publisher
Abstract
目的分析他汀类联合心血管药物治疗冠心病的临床疗效及对不良反应发生率的影响。方法将到我院诊治的166例冠心病患者选入本次研究,设立研究组、常规组,入院号为单数的患者归入研究组,双数的患者归入常规组,每组有83例,两组均应用常规心血管药物治疗,研究组在常规治疗的基础上结合瑞舒伐他汀治疗,观察两组患者的治疗效果、不良反应发生情况,对两组治疗前后的三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)水平进行统计。结果统计分析两组治疗有效率发现,研究组为98.80%,高于常规组的86.75%;对比不良反应发生情况,研究组不良反应率低于常规组(3.61%<12.05%);研究组治疗后的TG、TC、LDL-C、HDL-C各项水平改善更显著,P <0.05。结论他汀类联合心血管药物治疗冠心病的临床疗效优秀,不良反应发生情况较少
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Xiamen University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dspace.xmu.edu.cn:2288/174...
Last time updated on 20/11/2020